Home » Topics » BioWorld Science

BioWorld Science
RSS

New PCSK9 inhibitors discovered at Novartis

June 17, 2020

Pfizer describes new hemoglobin subunit beta polymerization inhibitors

June 17, 2020

Bisantrene phase II study in AML yields positive results

June 17, 2020

First patient dosed in dose-expansion stage of phase Ib/II trial of cavrotolimod

June 17, 2020

Positive data reported from phase II AFFIRM-35 study of ABY-035

June 17, 2020

Phase Ib data for ningetinib and gefitinib in EGFR-TKI-resistant NSCLC

June 17, 2020

MK-1092 demonstrates safety and promising glucose-lowering activity

June 17, 2020

KAND-567 demonstrates positive effect on mobility in a preclinical model of spinal cord injury

June 17, 2020

Phase IIa data reported for Sym-015 in non-small cell lung cancer patients

June 17, 2020

Staten begins first-in-human study of STT-5058 for hypertriglyceridemia

June 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...